Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Publication year range
1.
Tempus (Brasília) ; 14(2): 207-218, abri. 2020.
Article in Portuguese | LILACS | ID: biblio-1426485

ABSTRACT

O presente trabalho relata a experiência do uso de tecnologias de informação e comunicação no período de 2014 a 2019 como estratégia de atuação da assessoria de comunicação social do Conselho Nacional de Secretarias Municipais de Saúde (Conasems). (AU)


This paper reports the experience of the use of information and communication technologies from 2014 to 2019 as a strategy of action of the National Council of Municipal Health Secretariats' (Conasems) social communication advisory. (AU)


Este artículo informa la experiencia del uso de las tecnologías de la información y la comunicación desde 2014 hasta 2019 como estrategia de acción de la asesoría de comunicación social del Consejo Nacional de Secretarías Municipales de Salud (Conasems). (AU)


Subject(s)
Health Communication , Unified Health System , Public Health , Information Technologies and Communication Projects
2.
Acta Reumatol Port ; 42(2)(Apr-Jun): 112-126, 2017 06 01.
Article in English | MEDLINE | ID: mdl-28535544

ABSTRACT

OBJECTIVE: To update the recommendations for the treatment of Rheumatoid Arthritis (RA) with biological therapies, endorsed by the Portuguese Society of Rheumatology (SPR). METHODS: These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion. At a national meeting the 10 recommendations were discussed and updated. The document resulting from this meeting circulated to all Portuguese rheumatologists, who anonymously voted online on the level of agreement with the recommendations. RESULTS: These recommendations cover general aspects as shared decision, prospective registry in Reuma.pt, assessment of activity and RA impact and treatment objective. Consensus was also achieved regarding specific aspects as initiation of biologic therapy, assessment of response, switching and definition of persistent remission. CONCLUSION: These recommendations may be used for guidance of treatment with biological therapies in patients with RA. As more evidence becomes available and more therapies are licensed, these recommendations will be updated.

SELECTION OF CITATIONS
SEARCH DETAIL